ABOUT USATHERM

At the Forefront of Thermographic Imaging

Imaging. Reimagined.

USATherm was founded by Dr. Ariel Soffer and Dr. David Wright, two preeminent thought leaders in vascular medicine. They were seeking a more efficient approach to screen for chronic venous insufficiency and recognized the potential of thermography to visualize insufficient vessels and correlate them to ultrasound. 

The mission for USATherm is to establish thermographic imaging as an element in the standard engagement protocol for patients with venous disease.

improve patient care

Our Vision

simplify diagnosis
ThermPix was developed to allow for fast and easy identification of thermal patterns when paired with ultrasound
change the paradigm
The ease of use and convenience of ThermPix has the potential to change the way clinicians screen for venous disease
reach patients in need
The handheld contactless ThermPix can be used in virtually any setting to quickly view heat patterns.
build a platform
Point of Care Infrared Thermography has the potential for use in diagnosing several diseases in the body

adding value

Key Milestones to Date

2019
USATHERM FOUNDED
USATherm founded by Dr. Ariel Soffer and Dr. David Wright, two thought leaders in vascular medicine
2019
2020
PROOF OF CONCEPT
101 patients who underwent duplex ultrasound only were compared to 101 patients who underwent thermal imaging (TI) prior to duplex ultrasound. The introduction of TI resulted in a 24.6% increase in incompetent veins identified
2020
2021
FIRST PROTOTYPE
USATherm completes a finished device in preparation for FDA submission
2021
2022
FDA CLEARANCE
USATherm is granted FDA 510(k) clearance of the ThermPix device for adjunctive diagnostic imaging when used with other diagnostic medical devices
2022
2023
FDA CLEARANCE - 2ND GENERATION
USATherm is granted FDA 510(k) clearance on the 2nd generation ThermPix™ device for adjunctive diagnostic imaging when used with other diagnostic modalities
2023
2023
U.S. LAUNCH OF THERMPIX
USATherm launches ThermPix for vascular applications at the 2023 UIP World Congress & AVLS 37th Annual Congress
2023

USATherm Team



CHIEF EXECUTIVE OFFICER

CO-FOUNDER & CHIEF MEDICAL OFFICER

HEAD OF PRODUCT DEVELOPMENT

CHIEF TECHNOLOGY OFFICER

Board of Directors



FOUNDER & CHAIRMAN

CHIEF EXECUTIVE OFFICER

CO-FOUNDER & CHIEF MEDICAL OFFICER

Scientific Advisory Board



Advisors



Eric Heil

Chief Executive Officer

Mr. Heil is a highly experienced medical device executive with more than 25 years of executive leadership responsibility with multiple early-stage ventures as well as large multi-nationals.

He most recently served as Global Leader-Strategy and Therapy Advancement with Boston Scientific and prior with BTG as V.P. & G.M. Interventional Vascular

In addition, he has experience with early to mid-stage start-up/turn-arounds, venture and private equity backed companies leading to multiple, successful strategic exits, i.e. Covidien/Medtronic, Boston Scientific, Endosonics/Volcano & Roper Ind.

David Wright, M.D.

Co-Founder

Dr. Wright is a co-founder of USA Therm and a Fellow of the Royal College of Surgeons. As a vascular surgeon and medical physicist, Dr. Wright is a world-renowned thought leader in the diagnosis and treatment of venous disease

He had authored numerous peer-reviewed journal publications and holds several patents related to the treatment of venous insufficiency.

Dr. Wright was formerly the Vice President of Medical Affairs for Varithena at BTG International, which was acquired by Boston Scientific in 2019.

David McMahon

Head of Product Development

Experienced medical device executive and principal at Riverway Consulting who possesses entrepreneurial flair for building teams, business units and businesses from scratch. Track record of explosive growth and frugal approach to business creation. Commercial and R&D experience in both Medical Devices and Pharmaceuticals with large multi-nationals and early-stage start-ups, eg Johnson & Johnson, Cellnova, BTG International/Boston Scientific. Vast international Experience in EMEA, Asia and Americas including New Product Launch, Market Access and Commercial Partnering.

George Cain

Chief Technology Officer

Mr. Cain has 27 years of enterprise software experience with larger multi-nationals.

He has senior development experience with roles in the public safety sectors at Motorola and several healthcare management systems for private equity-backed startups.

In addition, he has 2 US patents for software applications.

Ariel Soffer, M.D.

Founder

Dr. Soffer is the Founder and Chairman of the Board of Directors of USA Therm.  He is a board certified practicing cardiologist and Fellow of the American College of Cardiology

In addition, he is a Clinical Asst. Prof., Cardiology NOVA Southeastern College of Allopathic Medicine

Dr. Soffer holds multiple medical imaging patents and is published in numerous peer-reviewed journals.  He founded and successfully exited a medical software company in 2021, AppwoRx, LLC.

Annerose Zorn

Advisor

Ms. Zorn is President of the Juzo Group, an organization specializing in the development and manufacturing of medical compression stockings. She has lead the company since 1980, which to date employs over 1,000 people around the world.

Stephen Elias, M.D.

Scientific Advisory Board

Dr Elias is director of the Center for Vein Disease at Englewood Hospital. He is board certified in venous and lymphatic medicine and in general surgery and completed a fellowship in vascular surgery at Englewood Hospital. Dr Elias is a Fellow of the American Board of Venous and Lymphatic Medicine and of the American College of Surgeons. He was previously the director of the vascular vein programs at the Mount Sinai Vein Center and at Columbia University. Dr Steve Elias is on the editorial board for Vascular and Endovascular Review Journal. He is the founder of the American Venous Forum Fellows Course in Vein Disease, as well as the founder and course director of the annual Expert Venous Management Summit.

Margaret Mann, M.D.

Scientific Advisory Board

Dr. Mann is the Co-Founder and the Director of Surgical and Aesthetic Services at Innova Dermatology.  Dr. Mann is a board-certified dermatologist with fellowship training in Mohs surgery, dermatologic surgery, cosmetic surgery and vein surgery. She is also an expert in venous disease  who received extensive training in the treatment of venous disease and minimally invasive cosmetic surgery. She is also the Associate Director of Dermatologic Surgery and an Associate Professor of Dermatology at Case Western Reserve School of Medicine. She served on the Board of Directors of the California Society Dermatology and Dermatologic Surgery and currently serves on the Board of Directors for the American Vein and Lymphatic Society as well as being an exam writer for the associated American Board of Venous & Lymphatic Medicine.

Bill Marston, M.D.

Scientific Advisory Board

Dr. Marston is currently the George Johnson Jr Distinguished Professor of Surgery and Chief of the Division of Vascular Surgery at the University of North Carolina School of Medicine. Also serves as Professor of Surgery; Medical Director, Wound Management Center at UNC Health. Dr Marston is a graduate of Harvard University and received his medical degree from the University of Virginia School of Medicine. He completed a general surgical residency and fellowship in vascular surgery at the University of North Carolina Hospitals in Chapel Hill, NC. His research interests include the diagnosis and management of chronic venous insufficiency, the treatment of critical limb ischemia, and advanced therapies for healing chronic wounds. He has been a clinical investigator on over 50 clinical trials in the areas listed above, both on the local and national level and has experience in the design and conduct of clinical trials at all levels of the approval process. He currently serves on the Editorial Board of the Journal of Vascular Surgery and on the Executive Councils of the American Venous Forum

Antonios P. Gasparis, M.D.

Scientific Advisory Board

Gasparis is the Professor of Surgery, Director – Center for Vein Care, Medical Director at Non-Invasive Vascular Laboratory, Medical Director at Bellavie MedSpa, Director at Phlebology Fellowship – Stony Brook University Medical Center, Stony Brook, NY, US. Dr Gasparis obtained his medical degree from SUNY-Syracuse and did his residency in general surgery. He did his fellowship training in Vascular Surgery at SUNY-Stony Brook and Endovascular Surgery at Texas Tec. His clinical interests and expertise reside in minimally invasive endovascular surgery for the management of aortic aneurysms, lower extremity vascular disease, carotid disease, and venous disease

Raghu Kollouri, M.D.

Scientific Advisory Board

Dr. Kolluri is the system medical director of Vascular Medicine at OhioHealth, responsible for the noninvasive vascular laboratories and vascular medicine program. He is an Adjunct Clinical Professor of Medicine at the Ohio University Heritage College of Osteopathic Medicine. He is the Past President of the Society for Vascular Medicine. His clinical practice is focused on the diagnosis and treatment of vascular disease. After graduating from Armed Forces Medical College, India, Dr. Kolluri completed his internal medicine residency at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, followed by vascular medicine fellowship training at the Cleveland Clinic.Considered a thought leader, Dr. Kolluri lectures worldwide on various subjects in the field of Vascular Medicine, including medical management of venous disease, venous ulcers, thrombosis, lymphedema, peripheral artery disease, and non-invasive imaging. He is a Fellow of the Society for Vascular Medicine, American College of Cardiology, American College of Physicians, Society for Cardiac Angiography and Interventions, and the American Heart Association.

Fedor Lurie, M.D.

Scientific Advisory Board

Dr Fedor Lurie is the Associate Director of the Jobst Vascular Institute, and Adjunct Research Professor at the Section of Vascular Surgery, University of Michigan. Dr Lurie’s clinical research included studies of vascular reconstructive surgery, natural history of vascular diseases, management of patients with acute DVT, and studies of compression therapy. His basic science research included vascular physiology and pathophysiology, venous valve function, and hemodynamic response to interventions. Dr Lurie serves as the Director of the American Board of Venous and Lymphatic Medicine, and he is Past President of the American Venous Forum and the American Venous Forum Foundation.  He is board certified in venous and lymphatic medicine and in general surgery and completed a fellowship in vascular surgery at Englewood Hospital. He is a Fellow of the American Board of Venous and Lymphatic Medicine and of the American College of Surgeons. He has been director of the vascular vein programs at the Mount Sinai Vein Center and at Columbia University.

Eric Hager, M.D.

Scientific Advisory Board

Dr. Hager serves as chief of vascular surgery at UPMC East and co-director of venous services at the UPMC Heart and Vascular Institute’s Vein Center. His clinical practice includes open surgical and endovascular treatment of aneurysms, carotid disease, peripheral vascular disease, and dialysis access. Dr. Hager earned his medical degree from Jefferson Medical College in Philadelphia, then completed a residency at Thomas Jefferson University Hospital. He completed a vascular surgery fellowship at UPMC and joined the division of Vascular Surgery in 2012. Dr. Hager has won various teaching awards through his training, and is a member of Alpha Omega Alpha, the medical honor society. He is an Associate Professor of Surgery and board-certified in general and vascular surgery, and specializes in treatment of venous disease. 

Mark Melin, M.D.

Advisor

Mark Melin, MD is a Wound Care Specialist at Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota. He received his medical degree from University of Minnesota. Dr. Melin did his residency in general surgery and his vascular fellowship at Mayo Clinic. His interests and educational niches include management of lymphedema/lymphatic stasis in the wounded patient, the endothelial glycocalyx, adjunctive micronutrient and bionutrient application to wound care, diosmin Micronized Purified Flavonoid Fraction (MPFF), polygenic abnormality impact upon wound resolution, wound pH and biofilm management, and emerging technologies in wound products and wound technologies. In 2022/2023, he participated in the educational activities of the University of Minnesota Wound Fellowship program, under the direction of the University of Minnesota PMR Department (Chair Dr. Leslie Morse and Fellowship Program Director Dr. Sandy Rosenberg), with the first Fellow initiating training in August 2022. The HBO Fellow from Hennepin County Medical Center (HCMC), Minneapolis, initiated a shadowing program in the Wound Healing Institute in August 2022 (HCMC Program Director Dr. Thomas Masters).

Craig Walker, MD

Advisor

Dr. Walker is board certified in internal medicine, cardiovascular disease, and interventional cardiology. He is a fellow of the American College of Cardiology, the American College of Physicians, the American Society of Cardiovascular Interventionists, the International College of Angiology, the Society for Cardiac Angiography and Interventions, the American College of Chest Physicians and the Council on Clinical Cardiology. He is a Clinical Professor of Medicine at LSU and Tulane Medical Schools. He is Clinical Editor of Vascular Disease Management and is on the editorial board of the Journal of Endovascular Therapy, Endovascular Today, Global Vascular Digest as well as many other vascular-based journals. Dr. Walker is on the Board of Directors of the Outpatient Endovascular and Interventional Society (OEIS). He has served as an associate director of multiple conferences throughout the US and the world. He is on the Scientific Board of Directors for many of the world’s largest peripheral interventional device companies.

Dr. Walker founded and is the chairman of New Cardiovascular Horizons. He established the conference to educate and train medical professionals on the latest techniques to treat coronary and peripheral vascular disease. From the beginning, this conference included multiple medical disciplines needed to ideally diagnose and treat PVD. It was the first conference to host a Critical Limb Ischemia Summit to address the challenges and improve therapy of CLI. In an effort to educate others on PVD, CLI and the relationship with cardiovascular diseases in general, Dr. Walker has created 18 regional Saturday conferences throughout the United States. These provide local updates on improvements in cardiovascular care as well as to stress the importance of peripheral, arterial, and venous disease diagnosis and treatment to primary care providers, interventionists, nurse practitioners, cath lab directors, and other allied health professionals.